METOLAZONE

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62332-534
  • Package NDC 62332-534-31
  • Package NDC 62332-534-91
  • Application number ANDA213251
  • SPL ID 4e197913-c368-474d-a147-e9ade3021e37
  • SPL set ID a84dbb37-648e-42d4-8688-ac39599284f0
  • UNII TZ7V40X7VX
  • RxCUI 197978
  • RxCUI 197979
  • RxCUI 311671

What the source publishes

Labeler
Alembic Pharmaceuticals Inc.
Active ingredients
METOLAZONE
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62332-534_4e197913-c368-474d-a147-e9ade3021e37
{
  "name": "METOLAZONE",
  "splId": "4e197913-c368-474d-a147-e9ade3021e37",
  "labels": [
    {
      "setId": "a84dbb37-648e-42d4-8688-ac39599284f0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a84dbb37-648e-42d4-8688-ac39599284f0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a84dbb37-648e-42d4-8688-ac39599284f0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Alembic Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (62332-534-31)",
      "package_ndc": "62332-534-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201202"
    },
    {
      "sample": false,
      "description": "1000 TABLET in 1 BOTTLE (62332-534-91)",
      "package_ndc": "62332-534-91",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201202"
    }
  ],
  "productId": "62332-534_4e197913-c368-474d-a147-e9ade3021e37",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "62332-534",
  "deaSchedule": null,
  "genericName": "METOLAZONE",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "METOLAZONE",
      "strength": "10 mg/1"
    }
  ],
  "applicationNumber": "ANDA213251",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20201202",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175359",
      "N0000175420"
    ],
    "upc": [
      "0362332534319",
      "0362332533312",
      "0362332532315"
    ],
    "unii": [
      "TZ7V40X7VX"
    ],
    "rxcui": [
      "197978",
      "197979",
      "311671"
    ],
    "spl_set_id": [
      "a84dbb37-648e-42d4-8688-ac39599284f0"
    ],
    "pharm_class_pe": [
      "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
      "Thiazide-like Diuretic [EPC]"
    ],
    "manufacturer_name": [
      "Alembic Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62332-534_4e197913-c368-474d-a147-e9ade3021e37"